Verrica Pharmaceuticals Q1 2026 Earnings EPS Miss Amid PreRevenue Stage Stock Rises 271 ASTL Q1 2026 Earnings EPS Surges Past Estimates by 42 Stock Jumps 7 ED Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher SNPS Q1 2026 Earnings Earnings Beat Estimates Stock Rises on Strong Performance SION Q1 2026 Earnings EPS Misses Consensus as PreRevenue Biotech Advances Pipeline Stock Edges Higher FGBI Q1 2026 Earnings Strong EPS Beat Overshadowed by Modest Stock Decline